American Healthcare REIT (AHR) Q3 2024: Managed Segment Drives 17% NOI Growth, Pipeline Expands Beyond $1B
American Healthcare REIT’s integrated strategy and full Trilogy ownership fueled a transformative quarter, with managed segments now generating two-thirds of cash NOI and external growth channels multiplying. Management’s disciplined capital allocation and operator-focused partnerships are unlocking both operational leverage and acquisition opportunities, positioning AHR for durable earnings expansion into 2025 and beyond.
Summary
- Trilogy Acquisition Reshapes Growth Platform: Full control of Trilogy enables deeper operational integration and recurring development pipeline.
- Managed Portfolio Now Dominates NOI: Hands-on asset management and selective operator curation accelerated margin and earnings gains.
- Capital Flexibility Expands Pipeline: Enhanced balance sheet and disciplined sourcing support robust external growth outlook.
Business Overview
American Healthcare REIT (AHR) is a diversified healthcare real estate investment trust focused on senior housing, skilled nursing, and outpatient medical properties. The company generates revenue through property ownership and management, leasing, and direct operations, with its portfolio segmented into integrated senior health campuses (Trilogy), SHOP (senior housing operating properties), triple-net leased properties, and outpatient medical buildings. As of Q3 2024, managed segments—Trilogy and SHOP—account for approximately 67% of AHR’s cash NOI, reflecting a strategic shift toward higher-margin, operationally intensive assets.
Performance Analysis
AHR delivered a quarter marked by exceptional operational execution and transformative capital allocation. The standout driver was the managed portfolio, which posted 17% same-store NOI growth year-over-year, with the Trilogy segment up 22.6% and SHOP soaring 61.8%. These segments now collectively contribute two-thirds of cash NOI, underscoring the business model’s evolution toward direct management and operational leverage.
Occupancy gains in assisted living and memory care, which carry higher margins and longer lengths of stay, outpaced skilled nursing, supporting both current margins and future growth. The acquisition of the remaining 24% minority interest in Trilogy, funded by a $471 million equity raise, consolidated full ownership and enabled direct capital allocation, further enhancing AHR’s ability to drive NOI and development. Balance sheet strength improved, with debt-to-EBITDA reduced by 1.5 turns since Q1, providing flexibility for disciplined external growth.
- Portfolio Mix Shift: Managed assets now comprise 67% of cash NOI, reflecting the REIT’s pivot toward higher-return, operator-driven segments.
- Operational Leverage: Incremental occupancy and rate management in assisted living and memory care are driving superior NOI expansion versus skilled nursing beds.
- Capital Allocation Impact: The Trilogy buyout, combined with select SHOP acquisitions, has set a foundation for recurring annual development and targeted external growth.
Expense controls and rate management continue to outpace inflationary pressures, and AHR’s selective approach to new acquisitions—favoring off-market and operator-sourced deals—positions the company for sustainable, accretive growth in a competitive landscape.
Executive Commentary
"Our operations strategy utilizes a hands-on asset management approach, which continues to drive outsized NOI growth, particularly within our managed segments, comprised of our integrated senior health campuses and our shop portfolios."
Danny Prosky, President and CEO
"We are increasing total portfolio 2024 same-store NOI growth guidance to 15% to 17%, which is up 300 basis points at the midpoint from our most recent guidance. This large increase is attributable to improved property performance, the buyout of the remainder of Trilogy that we did not own, and lower interest expense due to debt pay downs utilizing follow-on equity proceeds."
Brian Pei, Chief Financial Officer
Strategic Positioning
1. Full Ownership of Trilogy: Platform Integration and Recurring Growth
The buyout of Trilogy’s minority interest grants AHR full control over a proven, high-performing operator, allowing for direct capital allocation and streamlined decision-making. This enables annual development of new campuses and expansions, with management targeting $100 million to $200 million of recurring Trilogy development per year, plus the opportunity to acquire nine additional assets not yet fully owned.
2. Managed Portfolio Focus: Margin and NOI Expansion
Managed segments—Trilogy and SHOP—are now the economic engine of AHR, benefiting from hands-on asset management, selective operator partnerships, and best-practice sharing. The focus on higher-acuity assisted living and memory care, combined with Trilogy’s proprietary revenue management and employee retention programs, is driving sustained NOI and margin gains.
3. Disciplined External Growth: Relationship-Driven Sourcing
AHR is leveraging its operator network and lender relationships to source off-market and non-competitive acquisitions, avoiding broad auctions and bidding wars. Recent deals in Washington, Oregon, and Atlanta were secured through direct relationships, with underwriting focused on high single-digit to low double-digit stabilized yields. The pipeline of potential transactions now exceeds $1 billion, with $800 million on the SHOP side alone.
4. Capital Structure and Funding Hierarchy
Capital allocation remains disciplined, with a clear funding hierarchy: retained earnings, asset dispositions, and opportunistic equity issuance. The recent equity raise and deleveraging have positioned AHR to pursue growth without relying on a still-constrained secured debt market, supporting a conservative leverage profile and future flexibility.
5. Portfolio Rationalization: Outpatient Medical Dispositions
Non-core outpatient medical assets are being sold to improve portfolio quality and redeploy capital into higher-growth segments, with outpatient medical now down to 20% of NOI and expected to decline further. Dispositions are not required to fund growth but serve to optimize returns and align the portfolio with AHR’s strategic focus.
Key Considerations
The third quarter marks a strategic inflection for AHR, with the business model now anchored around operational leverage, selectivity in partner and asset mix, and disciplined capital deployment. Investors should monitor:
- Operator Platform Leverage: The ability to transfer Trilogy’s best practices—revenue management, marketing, employee retention—across SHOP operators could further amplify NOI growth.
- Occupancy and Mix Optimization: Continued gains in higher-margin assisted living and memory care settings are key to margin expansion and earnings durability.
- Acquisition Selectivity: Relationship-driven sourcing reduces competitive risk and supports higher deal quality, but requires ongoing diligence to maintain underwritten yields.
- Expense Management Discipline: Wage inflation and labor supply remain structural risks, but AHR’s scale and retention programs are mitigating factors.
- Capital Markets Access: Further deleveraging and prudent equity issuance will be critical as the REIT pursues its robust pipeline.
Risks
Labor market tightness and potential changes to immigration policy represent ongoing risks to wage growth and employee availability, which could pressure margins if not offset by rate management or occupancy gains. The outpatient medical segment continues to face churn, and while non-core dispositions improve portfolio quality, execution risk remains. Finally, the constrained secured debt market could limit flexibility if internal funding sources are depleted or equity markets turn less favorable.
Forward Outlook
For Q4 2024, AHR guided to:
- Same-store NOI growth of 15% to 17% for the full portfolio
- Normalized FFO per fully diluted share of $1.40 to $1.43 for the full year, up 16.5 cents at the midpoint from prior guidance
Management expects continued NOI and margin expansion in managed segments, ongoing portfolio rationalization, and robust external growth opportunities, with the pipeline exceeding $1 billion. The outlook excludes impact from unclosed transactions or additional equity/debt issuance.
- Trilogy development and SHOP acquisitions to remain primary growth drivers
- Expense management and operator integration to support margin resilience
Takeaways
AHR’s Q3 results demonstrate the power of its managed segment strategy and relationship-driven acquisition model.
- Managed Platform as Earnings Engine: Trilogy and SHOP’s operational leverage and occupancy gains are driving outsized NOI and FFO growth, with further upside from best-practice integration.
- Balance Sheet and Capital Allocation Discipline: Deleveraging and targeted equity issuance have restored capital flexibility, enabling accretive acquisitions without reliance on volatile debt markets.
- Growth Pipeline Visibility: With a $1 billion+ pipeline and recurring Trilogy development, AHR is well positioned for sustained external and organic growth into 2025.
Conclusion
American Healthcare REIT’s transformational quarter cements its evolution into a managed-segment-focused platform with durable earnings power and multiple avenues for external growth. The combination of operational rigor, disciplined capital allocation, and a robust acquisition pipeline positions AHR to outperform as demand for senior care accelerates.
Industry Read-Through
AHR’s results highlight a decisive industry pivot toward operator-driven, higher-acuity senior housing and away from lower-growth outpatient medical assets. The success of hands-on asset management, operator curation, and relationship-based deal sourcing suggests that scale and selectivity are increasingly critical for REITs seeking NOI and margin growth. Labor market dynamics remain a sector-wide challenge, but platforms with proven retention and training programs, like Trilogy, are best positioned to capture incremental demand. Investors should expect further consolidation, ongoing portfolio rationalization, and a premium on REITs with direct operational expertise and disciplined capital strategies.